Development and Marketing Agreement —Between— Boehringer Ingelheim International GmbH and InterMune Pharmaceuticals, Inc. March 23, 2001Development and Marketing Agreement • May 15th, 2001 • Intermune Pharmaceuticals Inc • Pharmaceutical preparations • New York
AMPHOTEC®/AMPHOCIL® PRODUCT ACQUISITION AGREEMENT BETWEEN ALZA CORPORATION AND INTERMUNE PHARMACEUTICALS, INC.Product Acquisition Agreement • May 15th, 2001 • Intermune Pharmaceuticals Inc • Pharmaceutical preparations • California
This Product Acquisition Agreement (the "Agreement") is made effective as of the 2nd day of January, 2001 between ALZA Corporation ("ALZA"), a Delaware corporation and InterMune Pharmaceuticals, Inc., a Delaware corporation ("InterMune").
AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • May 15th, 2001 • Intermune Pharmaceuticals Inc • Pharmaceutical preparations
January 25, 2001 Ms. Anna Hall Director of Business Development Genentech, Inc. 1 DNA Way South San Francisco CA 94080-4990 RE: AMENDMENT NO. 5 TO THE INTERMUNE/GENENTECH LICENSE AGREEMENT Dear Ms. Hall:License Agreement • May 15th, 2001 • Intermune Pharmaceuticals Inc • Pharmaceutical preparations
Please consider this document as Amendment No. 5 to that certain License Agreement for Interferon Gamma, dated May 5, 1998; as amended on December 26, 1998; January 15, 1999; April 27, 1999; and June 23, 2000 (collectively, the "Agreement"), between INTERMUNE PHARMACEUTICALS, INC. and GENENTECH, INC. (collectively, the "Parties").
Standard Form Office Lease Made and entered into at BURLINGAME, California, between HARVARD INVESTMENT CO. ("Lessor") and INTERMUNE, INC. ("Lessee")Intermune Pharmaceuticals Inc • May 15th, 2001 • Pharmaceutical preparations • California
